Business Description
Zealand Pharma A/S
ISIN : DK0060257814
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 13.7 | |||||
Equity-to-Asset | 0.8 | |||||
Debt-to-Equity | 0.08 | |||||
Debt-to-EBITDA | -0.17 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 52.79 | |||||
Beneish M-Score | -1.48 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.6 | |||||
3-Year EBITDA Growth Rate | 10.7 | |||||
3-Year EPS without NRI Growth Rate | 16.8 | |||||
3-Year FCF Growth Rate | 24.7 | |||||
3-Year Book Growth Rate | -4 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 21.24 | |||||
9-Day RSI | 28.72 | |||||
14-Day RSI | 37.17 | |||||
6-1 Month Momentum % | 142.41 | |||||
12-1 Month Momentum % | 210.18 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.25 | |||||
Quick Ratio | 6.23 | |||||
Cash Ratio | 5.74 | |||||
Days Inventory | 156.88 | |||||
Days Sales Outstanding | 171.95 | |||||
Days Payable | 3857.95 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -13.6 | |||||
Shareholder Yield % | -3.26 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 94.41 | |||||
Operating Margin % | -168.39 | |||||
Net Margin % | -205.3 | |||||
FCF Margin % | -131.11 | |||||
ROE % | -53.1 | |||||
ROA % | -38.73 | |||||
ROIC % | -229.43 | |||||
ROC (Joel Greenblatt) % | -368.56 | |||||
ROCE % | -42.77 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 101.23 | |||||
PB Ratio | 21.32 | |||||
Price-to-Tangible-Book | 21.47 | |||||
EV-to-EBIT | -50.73 | |||||
EV-to-EBITDA | -50.73 | |||||
EV-to-Revenue | 101.22 | |||||
EV-to-FCF | -77.48 | |||||
Price-to-Net-Current-Asset-Value | 24.37 | |||||
Price-to-Net-Cash | 27.25 | |||||
Earnings Yield (Greenblatt) % | -1.97 | |||||
FCF Yield % | -1.24 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Zealand Pharma A/S Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | 342.787 | ||
EPS (TTM) (kr) | -12.63 | ||
Beta | -0.23 | ||
Volatility % | 48.4 | ||
14-Day RSI | 37.17 | ||
14-Day ATR (kr) | 26.901824 | ||
20-Day SMA (kr) | 636.625 | ||
12-1 Month Momentum % | 210.18 | ||
52-Week Range (kr) | 212.2 - 749 | ||
Shares Outstanding (Mil) | 62.27 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Zealand Pharma A/S Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Zealand Pharma A/S Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
Zealand Pharma A/S Frequently Asked Questions
What is Zealand Pharma A/S(OCSE:ZEAL)'s stock price today?
When is next earnings date of Zealand Pharma A/S(OCSE:ZEAL)?
Does Zealand Pharma A/S(OCSE:ZEAL) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |